谷歌浏览器插件
订阅小程序
在清言上使用

325P A Phase II, Open-Label, Single-Center Study of QL1706 Plus Platinum Doublet Chemotherapy with or Without Bevacizumab As First-Line Treatment in Patients with Advanced NSCLC: Data from EGFR Wild-Type Cohort

Y. Huang,W. Fang,Y. Yang, Y. Zhao, H. Zhao, N. Zhou,Y. Zhang, L. Chen, T. Zhou, G. Chen,T. Wu, L. Lu,S. Xue, L. Zhang

Annals of oncology(2022)

引用 0|浏览24
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要